Simulation of the Regional Manifestation of Asthma

Journal of Pharmaceutical Sciences

Volumn 93, Issue 5, 2004, Pages 1205-1216

  Sbirlea Apiou, Gabriela ^a   Lemaire, Marc ^a   Katz, Ira ^b   Conway, Joy ^c   Fleming, John ^d   Martonen, Ted ^e  

^a AIR LIQUIDE   (France)

^b LAFAYETTE COLLEGE   (United States)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Disease simulations; Drug delivery; Mathematical modeling

Indexed keywords

AEROSOL; ARTICLE; ASTHMA; COMPARTMENT MODEL; DISEASE SIMULATION; DOSIMETRY; DRUG DELIVERY SYSTEM; LAMINAR FLOW; LUNG MODEL; MATHEMATICAL MODEL; TURBULENT FLOW;

EID: 1942434690     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20029     Document Type: Article

References (38)

1. Biesiada M, Zejda JE, Skiba M. 2000. Air pollution and acute respiratory diseases in children: Regression analysis of morbidity data. Int J Occup Med Environ Health 13:113-120.
2. Karpatova E, Michalickova J, Prikazsky V. 1993. Air pollution and the occurrence of recurrent respiratory tract diseases in children in the first years of life. Cesk Pediatr 48:354-359.
3. Lin CA, Martins MA, Farhat SC, Pope CA, Conceicao GM, Anastacio VM, Hatanaka M, Andrade WC, Hamaue WR, Bohm GM, Saldiva PH. 1999. Air pollution and respiratory illness of children in Sao Paulo, Brazil. Paediatr Perinat Epidemiol 13:475-488.
4. Jeffery PK. 1998. Investigation and assessment of airway and lung inflammation: We now have the tools, what are the questions? Eur Respir J 11:524-528.
5. Barnes PJ, Basbaum CB, Nadel JA, Roberts JM. 1978. Localization of β-adrenoreceptors in mammalian lung by light microscopic autoradiography. Nature 299:444-447.
6. Hensley MJ, O'Cain CF, McFadden ER, Jr., Ingram RH. 1978. Distribution of bronchodilation in normal subjects, beta agonist versus atropine. J Appl Physiol 45:778-782.
7. Newhouse MT, Ruffin RE. 1978. Deposition and fate of inhaled aerosols. Chest 73S:936-942.
8. Ruffin RE, Dolovich MB, Wolff RK, Newhouse MT. 1978. The effects of preferential deposition of histamine in the human airway. Am Rev Resp Dis 117:485-492.
9. Ruffin RE, Dolovich MB, Oldenberg FA, Jr., Newhouse MT. 1981. The preferential deposition of inhaled isoproterenol and propranolol in asthmatic patients. Chest 180S:904S-906S.
10. Clay MM, Pavia D, Clarke SW. 1986. Effect of aerosol particle size on bronchodilation with nebulized terbutaline in asthmatic subjects. Thorax 41:364-368.
11. Mitchell DM, Solomon MA, Tolfree SEJ, Short M, Spiro SG. 1987. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. Thorax 42:457-461.
12. Karlsson JA, Sant'Ambrogio G, Widdicombe J. 1988. Afferent neural pathways in cough and reflex bronchoconstriction. J Appl Physiol 65:1007-1023.
13. R). Eur Resp J 2:253-256.
14. Smaldone GC, Walser L, Perry RJ, Ilowite JS, Bennett WD, Greco M. 1989. Generation and administration of aerosols for medical and physiological research studies. J Aerosol Med 2:81-87.
15. Anderson PJ, Garshick E, Blanchard JD, Feldman HA, Brain JD. 1991. Intersubject variability in particle deposition does not explain variability in responsiveness to methacholine. Am Rev Resp Dis 144:649-654.
16. Ashworth HL, Wilson CG, Sims EE, Wotton PK, Hardy JG. 1991. Delivery of propellant soluble drug from a metered dose inhaler. Thorax 46:245-247.
17. Martonen TB. 1991. Aerosol therapy implications of particle deposition patterns in simulated human airways. J Aerosol Med 4:25-40.
18. Mortensen J, Groth S, Lange P, Hermansen F. 1991. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurized inhaler and a dry powder inhaler. Thorax 46:817-823.
19. Newman SP, Weisz AWB, Talee N, Clarke SW. 1991. Improvement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler technique. Thorax 46:712-716.
20. Vidgren M, Silvasti M, Vidgren P, Laurikainen K, Lehti H, Paronen P. 1991. Physical properties and clinical efficacy of two sodium cromoglycate inhalation aerosol preparations. Acta Pharm Nord 3: 1-4.
21. Vidgren P, Vidgren M, Laurikainen K, Pietil T, Silvasti M, Paronen P. 1991. In vitro deposition and clinical efficacy of two sodium cromoglycate inhalation powders. Int J Clin Pharm 29:108-112.
22. Groth ML, Foster WM. 1992. Aerosolized atropine sulfate, influence of inhalation pattern on effective blockade of vagal airway tone. Am Rev Resp Dis 145:215-219.
23. Martonen TB, Yang Y. 1996. Deposition mechanics of pharmaceutical particles in human airways. In: Hickey AJ, editor. Inhalation aerosols: Physical and biological basis for therapy. New York, NY: Marcel Dekker, Inc. pp 3-27.
24. Martonen TB, Musante CJ, Segal RA, Schroeter JD, Hwang D, Dolovich MA, Burton R, Spencer RM, Fleming JS. 2000. Lung models: Strengths and limitations. Resp Care 45:712-736.
25. Martonen TB, Schroeter JD, Hwang D, Fleming JS, Conway JH. 2000. Human lung morphology models for particle deposition studies. Inhal Toxicol 12: 109-121.
26. Smaldone GC, Perry RJ, Bennett WD, Messina MS, Zwang J, Ilowite J. 1988. Interpretation of 24 hour lung retention in studies of mucociliary clearance. J Aerosol Med 1:11-20.
27. Foster WM. 1988. Is 24-hour lung retention an index of alveolar deposition? J Aerosol Med 1:1-10.
28. Martonen TB, Zhang Z, Lessmann R. 1993. Fluid dynamics of the human larynx and upper tracheo-bronchial airways. Aerosol Sci Tech 19:133-156.
29. Martonen TB, Yang Y, Xue Z. 1994. Influences of cartilaginous rings on tracheobronchial fluid dynamics. Inhal Toxicol 6:185-203.
30. Martonen TB, Yang Y, Xue Z. 1994. Effects of carinal ridge shapes on lung airstreams. Aerosol Sci Tech 21:119-136.
31. Martonen TB, Guan X, Schreck RM. 2001. Fluid dynamics in airway bifurcations: I. Primary flows. Inhal Toxicol 13:261-279.
32. Martonen TB, Guan X, Schreck RM. 2001. Fluid dynamics in airway bifurcations: II. Secondary currents. Inhal Toxicol 13:281-289.
33. Martonen TB, Guan X, Schreck RM. 2001. Fluid dynamics in airway bifurcations: III. Localized flow conditions. Inhal Toxicol 13:307-324.
34. Carstairs JR, Nimmo AJ, Barnes PJ. 1985. Autoradiographic visualization of beta-adrenoceptor subtypes in human lungs. Am Rev Respir Dis 132:541-547.
35. Mak JC, Barnes PJ. 1990. Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lungs. Am Rev Respir Dis 141: 1559-1568.
36. Jeffrey PK. 1995. Structural, immunological and neural elements of the normal human airway wall. In: Busse W, Holgate S, editors. "Asthma and Rhinitis." Williston, VT: Blackwell Scientific Publishers. pp 80-108.
37. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, Hogg JC. 1997. Inflammation of small airways in asthma. J Allergy Clin Immunol 100:44-51.
38. Martonen TB, Fleming J, Schroeter J, Conway J, Hwang D. 2003. In silico modeling of asthma. Adv Drug Del Rev 55:829-849.